An anabolic steroid used mainly as an anabolic agent in veterinary practice.
These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power.
Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug.
A non-steroidal estrogen analog.
Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds.
The edible portions of any animal used for food including domestic mammals (the major ones being cattle, swine, and sheep) along with poultry, fish, shellfish, and game.
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
A 6-methyl PROGESTERONE acetate with reported glucocorticoid activity and effect on ESTRUS.
Organic silicon derivatives used to characterize hydroxysteroids, nucleosides, and related compounds. Trimethylsilyl esters of amino acids are used in peptide synthesis.
Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.
A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects.
A cabinet department in the Executive Branch of the United States Government concerned with improving and maintaining farm income and developing and expanding markets for agricultural products. Through inspection and grading services it safeguards and insures standards of quality in food supply and production.
Increase in BODY WEIGHT over existing weight.
Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure.
Slow or difficult OBSTETRIC LABOR or CHILDBIRTH.
The relative amounts of various components in the body, such as percentage of body fat.
A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed)
Developmental events leading to the formation of adult muscular system, which includes differentiation of the various types of muscle cell precursors, migration of myoblasts, activation of myogenesis and development of muscle anchorage.
Foodstuff used especially for domestic and laboratory animals, or livestock.
A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.
The consumption of edible substances.
An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites.
Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white.
A subtype of striated muscle, attached by TENDONS to the SKELETON. Skeletal muscles are innervated and their movement can be consciously controlled. They are also called voluntary muscles.
A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.
Cells derived from a FETUS that retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells.
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of ESTRADIOL to resemble TESTOSTERONE but less one carbon at the 19 position.
Particular categories of body build, determined on the basis of certain physical characteristics. The three basic body types are ectomorph (thin physique), endomorph (rounded physique), and mesomorph (athletic physique).
Illegitimate use of substances for a desired effect in competitive sports. It includes humans and animals.

Effects of implants on daily gains of steers wintered on dormant native tallgrass prairie, subsequent performance, and carcass characteristics. (1/144)

Fall-weaned crossbred steer calves (n = 300; 184 +/- 2.9 kg) received either no implant (Control) or were implanted with Synovex-C (SC = 10 mg estradiol benzoate + 100 mg progesterone), Synovex-S (SS = 20 mg estradiol benzoate + 200 mg progesterone), or Revalor-G (RG = 8 mg estradiol-17beta + 40 mg trenbolone acetate) to determine the effects of implants on weight gain during winter grazing on dormant tallgrass prairie, subsequent grazing and finishing performance, and carcass characteristics. Steers grazed two dormant tallgrass prairie pastures from October 16, 1996, until March 29, 1997 (164 d), and received 1.36 kg/d of a 25% CP supplement that supplied 100 mg of monensin/steer. Following winter grazing, all steers were implanted with Ralgro (36 mg zeranol) and grazed a common tallgrass prairie pasture until July 17 (110 d). After summer grazing, all steers were implanted with Revalor-S (24 mg estradiol-17beta + 120 mg trenbolone acetate), and winter implant treatment groups were equally allotted to four feedlot pens. Steers were harvested November 17, 1997, after a 123-d finishing period. Daily gains during the winter grazing phase averaged .28, .32, .32, or .35 kg/d, respectively, for Control, SC, SS, or RG steers and were greater (P < .01) for implanted steers than for Controls. Summer daily gains were similar (1.05 +/- .016 kg/d; P > or = .61) for all treatment groups. Feedlot daily gains were also similar (1.67 +/- .034 kg/d; P > or = .21), with implanted steers weighing 14 kg more than Control steers (P = .05) at harvest, despite similar management during summer grazing and feedlot phases. Control steers tended (P = .06) to have lower yield grades. There were no differences (P = .99) in marbling between implanted and nonimplanted steers. Steers implanted during the wintering phase had increased skeletal and overall (P < .01) carcass maturities compared with nonimplanted steers, which resulted in more "B" and "C" maturity carcasses. Because carcass maturity score affects quality grade, the increased maturities of implanted steers resulted in a $9.04 decrease in carcass value/100 kg (P < .01) compared with Controls. The results of this study indicate that growth-promoting implants are efficacious for cattle wintered on dormant native range despite low daily gains. This increased weight is maintained through the summer grazing and feedlot phases; however, the benefit of the increased weight may be offset by decreased carcass quality grade and value due to increased carcass maturity.  (+info)

Effect of anabolic implants on beef intramuscular lipid content. (2/144)

Sixty ribeye steaks were used to determine the effects of anabolic implants on i.m. lipid composition of beef steers. Steaks were obtained from carcasses (346 kg) of steers assigned to four treatment groups (C = nonimplanted control; ET = 28 mg of estradiol benzoate plus 200 mg of trenbolone acetate on d 0; ET/ET = ET on d 0 and d 61; and S/ET = 20 mg of estradiol benzoate plus 200 mg of progesterone on d 0 and ET on d 61) and fed a high-concentrate diet for 127 d. Total fatty acid content of the longissimus was less (P < .05) for implanted steers. Implanting increased (P < .05) stearic and linolenic acid percentages and reduced (P < .05) oleic acid percentage but did not alter (P > .05) percentages of other fatty acids. These changes translated into increased (P < .05) percentages of saturated fatty acids and reduced (P < .05) monounsaturated fatty acids in the longissimus of implanted steers. However, on a per-steak weight basis, implanting did not alter (P > .05) the amounts of any of the individual fatty acids, but it increased (P < .05) the total cholesterol amount. Implanting with an estrogenic compound first reduced (P < .05) the percentage and total amounts of linoleic and polyunsaturated fatty acids. On a percentage basis, implanting alters fatty acid amounts; however, when the increase in ribeye size with implanting is accounted for and fatty acids are evaluated on a per-steak basis, these differences are not significant.  (+info)

Implant sequence effects in intact male Holstein veal calves: live and slaughter traits. (3/144)

Seven sequences of growth promotant implants were used in special-fed intact male Holstein veal calves (n = 443). Calves received implants 4 d after arrival at the veal barn, 42, and 84. The following implants were used: placebo (0), Z (36 mg zeranol), ET (20 mg estradiol, 200 mg testosterone), EP/2 (10 mg estradiol, 100 mg progesterone), EP (20 mg estradiol, 200 mg progesterone), and EBA (24 mg estradiol, 120 mg trenbolone acetate). The following sequences were compared: 0-0-0 (negative control), 0-ET-ET, Z-ET-ET, 0-EP-EP, Z-EP-EP, 0-EP/2-EBA, and Z-0-EBA. From 0 to 42 d, Z implants increased (P<.05) ADG by 3.4% compared to placebo. However, implant schemes without an initial Z implant (0-ET-ET and 0-EP-EP) had higher (P<.05) mean ADG for the period from d 42 to 84. From 84 d to the end of the experiment, only the 0-EP/2-EBA treatment increased (P<.05) ADG compared to 0-0-0. Over the entire trial 0-ET-ET, 0-EP-EP, Z-EP-EP, and 0-EP/2-EBA implant sequences increased (P<.05) ADG by 3.2, 3.2, 2.4, and 4.7%, respectively, compared to the 0-0-0 sequence. Blood traits measured within 2 wk before slaughter were not affected by implant sequence, except that sequences with EP had higher (P<.05) leukocyte counts than were observed for the other sequences. Testicular weight was less (P<.01) for all of the implant sequences than for the negative control and less (P<.05) for Z-ET-ET than for 0-ET-ET, 0-EP-EP, 0-EP/2-EBA, and Z-0-EBA. The type and frequency of medical treatments did not differ among implant sequences for any of the 42-d phases, or over the entire trial. Generally, the growth promotant implants currently approved for beef cattle resulted in approximately 50% of the increase in growth rate in Holstein intact bull calves, as has been observed in beef-type steers or heifers.  (+info)

Implant sequence effects in intact male Holstein veal calves: carcass characteristics. (4/144)

Seven sequences of growth promotant implants were used in intact male Holstein veal calves (n = 443). Implants were administered on d 0 (within 4 d after arrival at the veal barn), 42, and 84. The implants used were placebo (0), Z (36 mg zeranol), ET (20 mg estradiol, 200 mg testosterone), EP/2 (10 mg estradiol, 100 mg progesterone), EP (20 mg estradiol, 200 mg progesterone), and EBA (24 mg estradiol, 120 mg trenbolone acetate). The following sequences were compared: 0-0-0 (negative control), 0-ET-ET, Z-ET-ET, 0-EP-EP, Z-EP-EP, 0-EP/2-EBA, and Z-0-EBA. Sequences 0-EP-EP, Z-EP-EP, and 0-EP/2-EBA increased (P<.05) carcass weight from 3.3 to 3.9% compared to nonimplanted controls. There were no differences (P>.05) in percentage of carcass weight accounted for by the fore vs. rear halves of carcasses, suggesting there was no difference in the distribution of weight. Although there were differences in longissimus area, the results were not consistent, except that there was a trend for longissimus area to be increased by the use of estrogenic-androgenic implants (ET and EBA). There were no differences among implant sequences for carcass conformation, fat cover, muscle texture, marbling/ feathering, muscle color, or muscle chemical composition. Of four implant sequences (0-0-0, 0-ET-ET, 0-EP-EP, and 0-EP/2-EBA) tested for differences in Warner-Bratzler shear force tenderness, the latter two sequences averaged higher (P<.05) for shear force than did the negative control. These results suggest that aggressive implant strategies in young, intact Holstein bull calves (raised as veal) have minimal effects on carcass characteristics.  (+info)

Effects of energy intake, implantation, and subcutaneous fat end point on feedlot steer performance and carcass composition. (5/144)

The purpose of this experiment was to evaluate the effects of energy intake, implantation, and fat end point on feedlot performance and carcass composition of steers. Three hundred eighty-four yearling crossbred steers (368 +/- 23.1 kg) were allotted in a completely randomized design. Treatments were arranged in a 2 x 3 x 2 factorial experiment. Main effect factors were two levels of intake, three implant strategies, and two compositional fat end points at slaughter. The levels of intake were ad libitum (AL) and restricted (RS) intake (90% ad libitum). The three implant strategies were Revalor-S (REV) (120 mg trenbolone acetate, 24 mg estradiol), Synovex-Plus (SYN) (200 mg trenbolone acetate, 28 mg estradiol benzoate), and no implant (control). The compositional target end points were 1.0 and 1.4 cm s.c. fat cover over the 12th and 13th rib. Restricted-intake steers consumed 9.2% less (P < .01) DM than AL steers. Ad libitum-intake steers gained weight 15.5% more rapidly (P < .01) than RS-intake steers. Steers implanted with REV tended (P < .07) to gain faster than SYN steers, who in turn gained 15.2% more (P < .01) than control steers. Ad libitum-intake steers were 4.8% more (P < .01) efficient than RS steers. Steers fed to a targeted 1.4 cm s.c. backfat cover were 2.9% less (P < .05) efficient than steers fed to 1.0 cm, and steers implanted with either REV or SYN had similar (P = .47) feed efficiencies, whereas control steers had lower (P < .01) feed efficiencies. Steers fed to a targeted compositional fat end point of 1.4 cm had 1.3% higher (P < .01) dressing percentage (DP) than steers fed to 1.0 cm. Control and SYN steers had similar (P = .13) DP; however, REV steers had 6.1% greater (P < .01) DP than SYN steers. Steers fed to 1.4 cm s.c. fat end point had higher (P < .01) numerical yield grades than steers fed to 1.0 cm (3.34 vs 2.71). There was an interaction (P < .01) for intake level and implant for marbling score. Marbling scores were lower (P < .05) for RS x SYN and AL x REV than in other treatments. Steers on the RS x REV treatment were intermediate in marbling to all treatments except AL control, which was higher (P < .01) than RS x SYN, AL x REV, and RS x REV. No interaction for dry matter intake level and anabolic implants was observed for growth performance. The depression in carcass quality resulting from implanting is reduced as backfat increases from 1.0 to 1.4 cm at slaughter.  (+info)

Body weight and tissue gain in lambs fed an all-concentrate diet and implanted with trenbolone acetate or grazed on alfalfa. (6/144)

Targhee x Hampshire lambs (average BW 23 +/- 1 kg) were used in two experiments to determine the effects of finishing on concentrate with an anabolic implant or forage grazing after concentrate feeding on growth, organ and viscera weights, and carcass tissue accretion. In Exp. 1 and 2 lambs were penned by sex and assigned for slaughter at initial (23 kg), intermediate (37 kg), or end BW (ewes, 47.7; wethers 50.4 kg). From 23 to 37 kg BW, lambs were fed all-concentrate diets in drylot (DL) or grazed on alfalfa (ALF). Experiment 1 was a 2 x 2 factorial with 28 lambs; factors were wether vs ewe lambs and unimplanted vs DL implanted with trenbolone acetate-estradiol benzoate. There were no differences in organ and viscera weights due to implant status. However, ADG (P < .03) and lean gain (P < .02) were greater for implanted than for unimplanted wethers (507 vs 357 g and 1,314 vs 656 g, respectively). Ewes did not respond to the implant. Fat accretion was not affected by implantation. Experiment 2 was a 2 x 3 factorial with 42 lambs; factors were wether vs ewe lambs and drylot during growing and finishing phases (DL-DL) vs drylot during growing and alfalfa grazing during finishing (DL-ALF) vs alfalfa grazing during growing and finishing phases (ALF-ALF). In Exp. 2, ADG of DL-DL lambs was greater (P < .01) than ADG of DL-ALF or ALF-ALF lambs. Lambs on ALF-ALF had smaller (P < .05) livers and rumen/reticulum weights but heavier (P < .04) kidney, omasum, small and large intestine, and cecum weights than those on DL. In Exp. 2, DL-ALF and ALF-ALF lambs had overall hindsaddle lean gain equal to those on DL-DL with less mesenteric fat and 100 g less separable fat. Finishing lambs on alfalfa reduced fat accretion without decreasing lean accretion, whereas trenbolone acetate implants for lambs fed concentrate increased BW gain and lean accretion without affecting fat accretion.  (+info)

The effects of grazing, liquid supplements, and implants on feedlot performance and carcass traits of Holstein steers. (7/144)

In each of 2 yr, 20 Holstein steers (185+/-7 kg initial BW) were allocated to each of three treatments: pastured for 4.5 mo on grass/legume pastures and then fed 80% corn diets (DM basis) until slaughter; pastured for 4.5 mo on grass/legume pastures with ad libitum access to molasses-based protein supplements and fed 80% corn diets until slaughter; and placed in a feedlot and fed only 80% corn diets until slaughter (FEEDLOT). Half of the steers in each treatment were initially implanted with Revalor-S and not reimplanted. Supplemented steers on pasture had greater (P < 0.05) ADG than unsupplemented steers, and FEEDLOT steers gained faster and were fatter (P < 0.05) after 4.5 mo. Implanted steers had greater (P < 0.05) ADG with no significant treatment x implant status effect. Supplement intake was variable and related to ambient temperature. During the feedlot phase, steers previously on pasture had greater DMI and ADG (P < 0.05) but were not more efficient than FEEDLOT steers. Percentage of USDA Choice carcasses, fat thickness, dressing percentage, yield grade, and final weight were greater (P < 0.05) for FEEDLOT steers than for steers on other treatments. Implanting increased ADG of all steers but did not affect carcass traits, carcass composition, or feedlot performance during the finishing phase. Holstein steers consuming supplemented and unsupplemented pasture before slaughter will be leaner, have lower carcass weights, and have generally lower quality grades than those fed exclusively in a feedlot when slaughtered at similar ages.  (+info)

Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods. (8/144)

Three in-vitro bioassays were used to compare the oestrogenic potency of chemicals used as growth promoter in beef cattle in certain non-European Union countries (17beta-oestradiol, alpha-zearalanol, testosterone, trenbolone, trenbolone acetate, melengestrol acetate) or found as food contaminant such as the mycotoxin zearalenone and some of their metabolites (17alpha-oestradiol, oestrone, 17alpha-epitestosterone, 19-nortestosterone, androstendione, zearalanone, alpha-zearalanol, beta-zearalanol, alpha-zearalenol, beta-zearalenol). The strong oestrogens 17alpha-ethinyl oestradiol and diethylstilboestrol were used as standards. The first bioassay was based on the activation of a reporter gene by oestrogens in recombinant yeast expressing human or rainbow trout oestrogen receptor. In the second bioassay, the vitellogenin gene induction of rainbow trout hepatocyte cultures was used as a biomarker for the exposure to oestrogens. The third bioassay was based on the alkaline phosphatase gene induction by oestrogens in the human endometrial Ishikawa cell line. The assessment of oestrogenic potency of these chemicals clearly demonstrates the strong oestrogenicity of the mycotoxin zearalenone and its metabolites and particularly alpha-zearalenol which was as potent as ethinyl oestradiol and diethylstilboestrol in the human endometrial Ishikawa cell line.  (+info)

Trenbolone Acetate is an esterified form of the synthetic steroid hormone Trenbolone. It is a potent anabolic and androgenic steroid, which is used in veterinary medicine for promoting muscle growth and appetite stimulation in cattle. In human medicine, it is not approved for use but is sometimes misused for its anabolic effects, such as increasing muscle mass, strength, and reducing body fat. It is important to note that the use of Trenbolone Acetate in humans is considered off-label and can lead to serious health consequences, including liver toxicity, cardiovascular issues, and hormonal imbalances.

Anabolic agents are a class of drugs that promote anabolism, the building up of body tissues. These agents are often used medically to help people with certain medical conditions such as muscle wasting diseases, osteoporosis, and delayed puberty. Anabolic steroids are one type of anabolic agent. They mimic the effects of testosterone, the male sex hormone, leading to increased muscle mass and strength. However, anabolic steroids also have significant side effects and can be addictive. Therefore, their use is regulated and they are only available by prescription in many countries. Abuse of anabolic steroids for non-medical purposes, such as to improve athletic performance or appearance, is illegal and can lead to serious health consequences.

A drug implant is a medical device that is specially designed to provide controlled release of a medication into the body over an extended period of time. Drug implants can be placed under the skin or in various body cavities, depending on the specific medical condition being treated. They are often used when other methods of administering medication, such as oral pills or injections, are not effective or practical.

Drug implants come in various forms, including rods, pellets, and small capsules. The medication is contained within the device and is released slowly over time, either through diffusion or erosion of the implant material. This allows for a steady concentration of the drug to be maintained in the body, which can help to improve treatment outcomes and reduce side effects.

Some common examples of drug implants include:

1. Hormonal implants: These are small rods that are inserted under the skin of the upper arm and release hormones such as progestin or estrogen over a period of several years. They are often used for birth control or to treat conditions such as endometriosis or uterine fibroids.
2. Intraocular implants: These are small devices that are placed in the eye during surgery to release medication directly into the eye. They are often used to treat conditions such as age-related macular degeneration or diabetic retinopathy.
3. Bone cement implants: These are specially formulated cements that contain antibiotics and are used to fill bone defects or joint spaces during surgery. The antibiotics are released slowly over time, helping to prevent infection.
4. Implantable pumps: These are small devices that are placed under the skin and deliver medication directly into a specific body cavity, such as the spinal cord or the peritoneal cavity. They are often used to treat chronic pain or cancer.

Overall, drug implants offer several advantages over other methods of administering medication, including improved compliance, reduced side effects, and more consistent drug levels in the body. However, they may also have some disadvantages, such as the need for surgical placement and the potential for infection or other complications. As with any medical treatment, it is important to discuss the risks and benefits of drug implants with a healthcare provider.

Zeranol is not a medical term per se, but it is a chemical compound used in veterinary medicine and agriculture. Zeranol is a non-steroidal estrogenic growth promoter, which means it is used to promote growth in animals, particularly cattle. It belongs to the class of compounds known as zearalenones, which are mycotoxins produced by certain types of fungi.

Zeranol works by binding to estrogen receptors in the animal's body, mimicking the effects of natural estrogens and promoting growth. It is important to note that zeranol is not approved for use in humans, and its potential health effects on humans are not well understood. However, residues of zeranol have been found in meat products derived from cattle treated with the compound, leading to concerns about its potential impact on human health.

I apologize, but "estrenes" is not a term commonly used in medical terminology in English. It may be a term used in another language or context. If you could provide more context or clarify what you are looking for, I would be happy to help further.

In a medical context, "meat" generally refers to the flesh of animals that is consumed as food. This includes muscle tissue, as well as fat and other tissues that are often found in meat products. However, it's worth noting that some people may have dietary restrictions or medical conditions that prevent them from consuming meat, so it's always important to consider individual preferences and needs when discussing food options.

It's also worth noting that the consumption of meat can have both positive and negative health effects. On the one hand, meat is a good source of protein, iron, vitamin B12, and other essential nutrients. On the other hand, consuming large amounts of red and processed meats has been linked to an increased risk of heart disease, stroke, and certain types of cancer. Therefore, it's generally recommended to consume meat in moderation as part of a balanced diet.

"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.

Estradiol is a type of estrogen, which is a female sex hormone. It is the most potent and dominant form of estrogen in humans. Estradiol plays a crucial role in the development and maintenance of secondary sexual characteristics in women, such as breast development and regulation of the menstrual cycle. It also helps maintain bone density, protect the lining of the uterus, and is involved in cognition and mood regulation.

Estradiol is produced primarily by the ovaries, but it can also be synthesized in smaller amounts by the adrenal glands and fat cells. In men, estradiol is produced from testosterone through a process called aromatization. Abnormal levels of estradiol can contribute to various health issues, such as hormonal imbalances, infertility, osteoporosis, and certain types of cancer.

Melengestrol Acetate (MGA) is a synthetic progestin, which is a type of steroid hormone. It is used primarily as a growth promoter in the livestock industry to increase weight gain and feed efficiency in beef cattle. MGA works by suppressing the animal's natural hormonal balance, particularly the levels of estrogen and testosterone, which leads to changes in metabolism and behavior that promote weight gain.

It is not approved for use in humans in many countries, including the United States, due to concerns about potential health risks associated with its long-term use, such as reproductive and developmental effects. However, it has been used off-label in some cases to treat certain medical conditions in women, such as endometriosis or abnormal uterine bleeding, under the close supervision of a healthcare provider.

Trimethylsilyl compounds are organosilicon substances that contain the functional group Si(CH3)3-, known as a trimethylsilyl group. These compounds are widely used in various fields, including chemistry and biochemistry, as reagents, protecting groups, or derivatizing agents.

In a medical context, trimethylsilyl compounds may be encountered in the analysis of biological samples, such as blood, urine, or tissues, using techniques like gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS). These methods often require the derivatization of polar or labile compounds to increase their volatility and thermal stability. Trimethylsilylating agents, such as trimethylsilyl chloride (TMSCl) or N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA), are commonly used to convert polar functional groups like hydroxyl (-OH), amino (-NH2), or carboxyl (-COOH) into their corresponding trimethylsilyl ethers, esters, or amides. This derivatization process facilitates the separation and detection of these compounds in complex biological matrices.

It is important to note that direct exposure to some trimethylsilyl compounds may cause irritation to the skin, eyes, and respiratory tract; therefore, appropriate safety measures should be taken when handling these substances.

A drug combination refers to the use of two or more drugs in combination for the treatment of a single medical condition or disease. The rationale behind using drug combinations is to achieve a therapeutic effect that is superior to that obtained with any single agent alone, through various mechanisms such as:

* Complementary modes of action: When different drugs target different aspects of the disease process, their combined effects may be greater than either drug used alone.
* Synergistic interactions: In some cases, the combination of two or more drugs can result in a greater-than-additive effect, where the total response is greater than the sum of the individual responses to each drug.
* Antagonism of adverse effects: Sometimes, the use of one drug can mitigate the side effects of another, allowing for higher doses or longer durations of therapy.

Examples of drug combinations include:

* Highly active antiretroviral therapy (HAART) for HIV infection, which typically involves a combination of three or more antiretroviral drugs to suppress viral replication and prevent the development of drug resistance.
* Chemotherapy regimens for cancer treatment, where combinations of cytotoxic agents are used to target different stages of the cell cycle and increase the likelihood of tumor cell death.
* Fixed-dose combination products, such as those used in the treatment of hypertension or type 2 diabetes, which combine two or more active ingredients into a single formulation for ease of administration and improved adherence to therapy.

However, it's important to note that drug combinations can also increase the risk of adverse effects, drug-drug interactions, and medication errors. Therefore, careful consideration should be given to the selection of appropriate drugs, dosing regimens, and monitoring parameters when using drug combinations in clinical practice.

"Random allocation," also known as "random assignment" or "randomization," is a process used in clinical trials and other research studies to distribute participants into different intervention groups (such as experimental group vs. control group) in a way that minimizes selection bias and ensures the groups are comparable at the start of the study.

In random allocation, each participant has an equal chance of being assigned to any group, and the assignment is typically made using a computer-generated randomization schedule or other objective methods. This process helps to ensure that any differences between the groups are due to the intervention being tested rather than pre-existing differences in the participants' characteristics.

The United States Department of Agriculture (USDA) is not a medical organization or entity, so it does not provide medical definitions. However, I can give you some information about what the USDA is and what it does.

The USDA is a federal executive department of the U.S. government responsible for developing and executing federal laws related to farming, forestry, and food. It was established in 1862 by President Abraham Lincoln and is headed by the Secretary of Agriculture, who is a member of the President's cabinet.

The USDA has several key missions, including:

* Promoting agricultural trade and production
* Ensuring the safety of the food supply
* Providing nutrition assistance to vulnerable populations
* Protecting natural resources and the environment
* Promoting rural development and economic stability

In terms of food and nutrition, the USDA plays an important role in setting dietary guidelines for Americans, establishing standards for school meals and other federal food programs, and regulating the safety of meat, poultry, and egg products. The agency also conducts research on agricultural and food-related topics and provides education and outreach to farmers, ranchers, and consumers.

Weight gain is defined as an increase in body weight over time, which can be attributed to various factors such as an increase in muscle mass, fat mass, or total body water. It is typically measured in terms of pounds or kilograms and can be intentional or unintentional. Unintentional weight gain may be a cause for concern if it's significant or accompanied by other symptoms, as it could indicate an underlying medical condition such as hypothyroidism, diabetes, or heart disease.

It is important to note that while body mass index (BMI) can be used as a general guideline for weight status, it does not differentiate between muscle mass and fat mass. Therefore, an increase in muscle mass through activities like strength training could result in a higher BMI, but this may not necessarily be indicative of increased health risks associated with excess body fat.

Acetates, in a medical context, most commonly refer to compounds that contain the acetate group, which is an functional group consisting of a carbon atom bonded to two hydrogen atoms and an oxygen atom (-COO-). An example of an acetate is sodium acetate (CH3COONa), which is a salt formed from acetic acid (CH3COOH) and is often used as a buffering agent in medical solutions.

Acetates can also refer to a group of medications that contain acetate as an active ingredient, such as magnesium acetate, which is used as a laxative, or calcium acetate, which is used to treat high levels of phosphate in the blood.

In addition, acetates can also refer to a process called acetylation, which is the addition of an acetyl group (-COCH3) to a molecule. This process can be important in the metabolism and regulation of various substances within the body.

Dystocia is a medical term used to describe difficult or abnormal labor or delivery in animals, including humans. It refers to a situation where the natural process of childbirth is hindered or obstructed, making it difficult for the fetus to pass through the birth canal. This condition can be caused by various factors such as the size and position of the fetus, maternal pelvic size or shape, hormonal imbalances, or other medical conditions that affect the mother's ability to give birth.

Dystocia can lead to serious complications for both the mother and the fetus if not treated promptly and appropriately. Prolonged labor can result in fetal distress, hypoxia (lack of oxygen), or even death. In addition, maternal injuries such as uterine rupture, cervical trauma, or infection can occur during a difficult delivery.

The treatment for dystocia depends on the underlying cause and severity of the condition. In some cases, manual assistance or manipulation of the fetus may be sufficient to facilitate delivery. However, in more severe cases, medical intervention such as cesarean section (C-section) may be necessary to ensure the safety of both the mother and the fetus.

It is important for pregnant individuals to receive regular prenatal care from a qualified healthcare provider to monitor their pregnancy and identify any potential risk factors for dystocia or other complications. Prompt medical attention should be sought if any signs of difficult labor or delivery are observed.

Body composition refers to the relative proportions of different components that make up a person's body, including fat mass, lean muscle mass, bone mass, and total body water. It is an important measure of health and fitness, as changes in body composition can indicate shifts in overall health status. For example, an increase in fat mass and decrease in lean muscle mass can be indicative of poor nutrition, sedentary behavior, or certain medical conditions.

There are several methods for measuring body composition, including:

1. Bioelectrical impedance analysis (BIA): This method uses low-level electrical currents to estimate body fat percentage based on the conductivity of different tissues.
2. Dual-energy X-ray absorptiometry (DXA): This method uses low-dose X-rays to measure bone density and body composition, including lean muscle mass and fat distribution.
3. Hydrostatic weighing: This method involves submerging a person in water and measuring their weight underwater to estimate body density and fat mass.
4. Air displacement plethysmography (ADP): This method uses air displacement to measure body volume and density, which can be used to estimate body composition.

Understanding body composition can help individuals make informed decisions about their health and fitness goals, as well as provide valuable information for healthcare providers in the management of chronic diseases such as obesity, diabetes, and heart disease.

Phenethylamines are a class of organic compounds that share a common structural feature, which is a phenethyl group (a phenyl ring bonded to an ethylamine chain). In the context of pharmacology and neuroscience, "phenethylamines" often refers to a specific group of psychoactive drugs, including stimulants like amphetamine and mescaline, a classic psychedelic. These compounds exert their effects by modulating the activity of neurotransmitters in the brain, such as dopamine, norepinephrine, and serotonin. It is important to note that many phenethylamines have potential for abuse and are controlled substances.

Muscle development, also known as muscle hypertrophy, refers to the increase in size and mass of the muscles through a process called myofiber growth. This is primarily achieved through resistance or strength training exercises that cause micro-tears in the muscle fibers, leading to an inflammatory response and the release of hormones that promote muscle growth. As the muscles repair themselves, they become larger and stronger than before. Proper nutrition, including adequate protein intake, and rest are also essential components of muscle development.

It is important to note that while muscle development can lead to an increase in strength and muscular endurance, it does not necessarily result in improved athletic performance or overall fitness. A well-rounded exercise program that includes cardiovascular activity, flexibility training, and resistance exercises is recommended for optimal health and fitness outcomes.

Animal feed refers to any substance or mixture of substances, whether processed, unprocessed, or partially processed, which is intended to be used as food for animals, including fish, without further processing. It includes ingredients such as grains, hay, straw, oilseed meals, and by-products from the milling, processing, and manufacturing industries. Animal feed can be in the form of pellets, crumbles, mash, or other forms, and is used to provide nutrients such as energy, protein, fiber, vitamins, and minerals to support the growth, reproduction, and maintenance of animals. It's important to note that animal feed must be safe, nutritious, and properly labeled to ensure the health and well-being of the animals that consume it.

Testosterone is a steroid hormone that belongs to androsten class of hormones. It is primarily secreted by the Leydig cells in the testes of males and, to a lesser extent, by the ovaries and adrenal glands in females. Testosterone is the main male sex hormone and anabolic steroid. It plays a key role in the development of masculine characteristics, such as body hair and muscle mass, and contributes to bone density, fat distribution, red cell production, and sex drive. In females, testosterone contributes to sexual desire and bone health. Testosterone is synthesized from cholesterol and its production is regulated by luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

The medical definition of "eating" refers to the process of consuming and ingesting food or nutrients into the body. This process typically involves several steps, including:

1. Food preparation: This may involve cleaning, chopping, cooking, or combining ingredients to make them ready for consumption.
2. Ingestion: The act of taking food or nutrients into the mouth and swallowing it.
3. Digestion: Once food is ingested, it travels down the esophagus and enters the stomach, where it is broken down by enzymes and acids to facilitate absorption of nutrients.
4. Absorption: Nutrients are absorbed through the walls of the small intestine and transported to cells throughout the body for use as energy or building blocks for growth and repair.
5. Elimination: Undigested food and waste products are eliminated from the body through the large intestine (colon) and rectum.

Eating is an essential function that provides the body with the nutrients it needs to maintain health, grow, and repair itself. Disorders of eating, such as anorexia nervosa or bulimia nervosa, can have serious consequences for physical and mental health.

Cyproterone acetate is a synthetic steroid hormone with anti-androgen and progestogenic properties. It works by blocking the action of androgens (male sex hormones) in the body, which helps to reduce symptoms associated with excessive androgen production such as severe acne or hirsutism (excessive hair growth).

Cyproterone acetate is used in the treatment of conditions such as prostate cancer, where it can help to slow the growth of cancer cells by reducing the levels of androgens in the body. It is also used in the treatment of sexual deviations, such as pedophilia or exhibitionism, as it can reduce sexual desire.

In addition, cyproterone acetate is sometimes used in combination with estrogen in hormone replacement therapy for transgender women to suppress the production of testosterone and promote feminization.

It's important to note that cyproterone acetate can have significant side effects and its use should be under the close supervision of a healthcare professional.

Adipose tissue, also known as fatty tissue, is a type of connective tissue that is composed mainly of adipocytes (fat cells). It is found throughout the body, but is particularly abundant in the abdominal cavity, beneath the skin, and around organs such as the heart and kidneys.

Adipose tissue serves several important functions in the body. One of its primary roles is to store energy in the form of fat, which can be mobilized and used as an energy source during periods of fasting or exercise. Adipose tissue also provides insulation and cushioning for the body, and produces hormones that help regulate metabolism, appetite, and reproductive function.

There are two main types of adipose tissue: white adipose tissue (WAT) and brown adipose tissue (BAT). WAT is the more common form and is responsible for storing energy as fat. BAT, on the other hand, contains a higher number of mitochondria and is involved in heat production and energy expenditure.

Excessive accumulation of adipose tissue can lead to obesity, which is associated with an increased risk of various health problems such as diabetes, heart disease, and certain types of cancer.

Skeletal muscle, also known as striated or voluntary muscle, is a type of muscle that is attached to bones by tendons or aponeuroses and functions to produce movements and support the posture of the body. It is composed of long, multinucleated fibers that are arranged in parallel bundles and are characterized by alternating light and dark bands, giving them a striped appearance under a microscope. Skeletal muscle is under voluntary control, meaning that it is consciously activated through signals from the nervous system. It is responsible for activities such as walking, running, jumping, and lifting objects.

Insulin-like growth factor I (IGF-I) is a hormone that plays a crucial role in growth and development. It is a small protein with structural and functional similarity to insulin, hence the name "insulin-like." IGF-I is primarily produced in the liver under the regulation of growth hormone (GH).

IGF-I binds to its specific receptor, the IGF-1 receptor, which is widely expressed throughout the body. This binding activates a signaling cascade that promotes cell proliferation, differentiation, and survival. In addition, IGF-I has anabolic effects on various tissues, including muscle, bone, and cartilage, contributing to their growth and maintenance.

IGF-I is essential for normal growth during childhood and adolescence, and it continues to play a role in maintaining tissue homeostasis throughout adulthood. Abnormal levels of IGF-I have been associated with various medical conditions, such as growth disorders, diabetes, and certain types of cancer.

Fetal stem cells are a type of stem cell that are derived from fetal tissue, which is tissue obtained from an elective abortion or a spontaneous miscarriage. These stem cells have the ability to differentiate into various cell types, including neurons, cardiac muscle cells, and hepatocytes (liver cells). Fetal stem cells are unique in that they have a greater capacity for self-renewal and can generate a larger number of differentiated cells compared to adult stem cells. They also have the potential to be less immunogenic than other types of stem cells, making them a promising candidate for cell-based therapies and regenerative medicine. However, the use of fetal stem cells is a subject of ethical debate due to their source.

Body weight is the measure of the force exerted on a scale or balance by an object's mass, most commonly expressed in units such as pounds (lb) or kilograms (kg). In the context of medical definitions, body weight typically refers to an individual's total weight, which includes their skeletal muscle, fat, organs, and bodily fluids.

Healthcare professionals often use body weight as a basic indicator of overall health status, as it can provide insights into various aspects of a person's health, such as nutritional status, metabolic function, and risk factors for certain diseases. For example, being significantly underweight or overweight can increase the risk of developing conditions like malnutrition, diabetes, heart disease, and certain types of cancer.

It is important to note that body weight alone may not provide a complete picture of an individual's health, as it does not account for factors such as muscle mass, bone density, or body composition. Therefore, healthcare professionals often use additional measures, such as body mass index (BMI), waist circumference, and blood tests, to assess overall health status more comprehensively.

Nandrolone is a synthetic anabolic-androgenic steroid, which is a type of hormone that is similar to testosterone. It is often used in medical settings for the treatment of certain conditions such as muscle wasting diseases, osteoporosis, and breast cancer in women. Nandrolone promotes muscle growth and increases appetite, which can help individuals with muscle wasting diseases or other conditions that cause muscle loss to maintain their strength and weight.

Nandrolone is also known by its brand names Deca-Durabolin and Durabolin. It works by increasing the production of proteins in the body, which helps to build muscle mass. Nandrolone can have both anabolic (muscle-building) and androgenic (masculinizing) effects, although it is generally considered to be less androgenic than testosterone.

Like other anabolic steroids, nandrolone can have a number of side effects, including acne, hair loss, liver damage, and mood changes. It can also cause virilization in women, which refers to the development of male characteristics such as a deep voice, facial hair, and a decrease in breast size. Nandrolone is classified as a controlled substance in many countries due to its potential for abuse and dependence.

Somatotype is a term used in the field of human biology and medicine, particularly in anthropometry, which refers to the scientific study of measurements of the human body. It was introduced by American psychologist William H. Sheldon in the 1940s as part of his concept of "constitutional psychology."

Somatotype is a classification system that categorizes human body types based on their skeletal frame, muscle development, and body fat distribution. The system uses a three-number rating scale to describe an individual's somatotype, with each number ranging from 1 to 7:

1. Endomorphy (softness, roundness): Refers to the degree of relative body fatness or adiposity, which is determined by measuring skinfold thicknesses at various sites on the body. Higher values indicate a greater amount of body fat.
2. Mesomorphy (muscularity, hardness): Represents the degree of muscular development and bone structure, assessed through measurements of muscle circumferences and skeletal breadths. Higher values suggest a more muscular and robust build.
3. Ectomorphy (linearity, slenderness): Describes the relative leanness and linearity of the body, evaluated using height-to-weight ratios and other anthropometric measures. Higher values indicate a leaner and more delicate physique.

An individual's somatotype is typically expressed as a set of three numbers, such as 4-6-2 or 2-5-3, representing their endomorphy, mesomorphy, and ectomorphy ratings, respectively. It is important to note that somatotypes are not fixed and can change over time due to factors like aging, lifestyle choices, and exercise habits.

While Sheldon's constitutional psychology theory has been largely discredited, the concept of somatotyping remains a valuable tool in various fields such as sports science, health, and fitness for assessing and comparing body composition and structure.

Doping in sports is the use of prohibited substances or methods to improve athletic performance. The World Anti-Doping Agency (WADA) defines doping as "the occurrence of one or more of the following anti-doping rule violations":

1. Presence of a prohibited substance in an athlete's sample
2. Use or attempted use of a prohibited substance or method
3. Evading, refusing, or failing to submit to sample collection
4. Whereabouts failures (three missed tests or filing failures within a 12-month period)
5. Tampering or attempted tampering with any part of the doping control process
6. Possession, trafficking, or administration of a prohibited substance or method
7. Complicity in an anti-doping rule violation
8. Prohibited association with a person who has been serving a period of ineligibility for an anti-doping rule violation

Doping is considered unethical and harmful to the integrity of sports, as it provides an unfair advantage to those who engage in it. It can also have serious health consequences for athletes. Various international and national organizations, including WADA and the United States Anti-Doping Agency (USADA), work to prevent doping in sports through education, testing, and enforcement of anti-doping rules.

No FAQ available that match "trenbolone acetate"

No images available that match "trenbolone acetate"